our results showed that gm-csf is a potent stimulator of hematopoiesis in vivo and may produce hematologic improvement in the short term ( 8 to 32 weeks of observation ) in patients with myelodysplastic syndrome .
C0079460
gm-csf
C0018951
hematopoiesis